Together, these experimental results are consistent with the findings of several studies that RA patients who test positive for IgA autoantibodies develop more severe disease and experience more bone erosion than RA patients who test negative for IgA autoantibodies [55,122,123]. This evidence concerns the gene CD79A and rheumatoid arthritis.